Date de publication: 11 mai 2017
Promoteur – Intermédiaire Financier
VIRBAC SALieu
Description
Investment to support research and development (R&D) for a robust portfolio of next-generation innovative products, addressing global animal health issues, to support Virbac's organic growth and international expansion. The project will be largely coordinated and implemented at the company's French R&D sites.
Objectifs
The project will support the long-term innovation-driven organic growth of the company while enlarging its product portfolio, strengthening its competitive edge and scaling up market share as global player.
Secteur(s)
- Industrie - Industrie manufacturière
Montant BEI envisagé (montant approximatif)
EUR 77 million
Coût total (montant approximatif)
EUR 250 million
Aspects environnementaux
All project activities are expected to be carried out in existing facilities and laboratories without changing their already authorised scope and would therefore not require an environmental impact assessment (EIA) under Directive 2011/92/EU, as amended. Nevertheless, the Bank's services will review during the project appraisal whether any of the investments requires an EIA, as well as any other environmental details of the project.
Passation des marchés
The promoter has been assessed by the EIB as being a private company not operating in the utilities sector and not having the status of a contracting entity, thus not subject to EU rules on public procurement.
Statut
Signé - 25/07/2017
Clause de non-responsabilité
Avant d’être approuvés par le Conseil d’administration et avant la signature des prêts correspondants, les projets font l’objet d’une instruction et de négociations. Par conséquent, les informations et données fournies sur cette page sont indicatives.
Elles sont fournies à des fins de transparence uniquement et ne peuvent être considérées comme représentant la politique officielle de la BEI (voir également les notes explicatives).